Oncosis Receives $6.7M SBIR Grant | GenomeWeb

NEW YORK, Dec 12 – Oncosis said Tuesday it received a four-year, $6.7 million Small Business Innovation Research grant from the National Institutes of Health to develop its Photosis technology.

Photosis is an automated, laser-based cell treatment system that has clinical and genomic applications, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.